Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (251-260 of 494) with videos related to

Pageof 50
Sort By:
Breast Cancer (Tokyo, Japan)|October 9, 2021
6q deletion is frequent but unrelated to patient prognosis in breast cancerPatrick Lebok, Hannah Bönte, Martina Kluth, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Nature Communications|December 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancerMigle Mikutenaite, Evdoxia Karadoulama, Francesco Favero, et al.
Clinical & Experimental Metastasis|October 25, 2020
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancerHannah Voß, Marcus Wurlitzer, Daniel J Smit, et al.
BMC Cancer|July 28, 2017
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerFrank Jacobsen, Billurvan Taskin, Nathaniel Melling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
Pageof 50

Showing results (251-260 of 494) with videos related to

Sort By:
Pageof 50
Breast Cancer (Tokyo, Japan)|October 9, 2021
6q deletion is frequent but unrelated to patient prognosis in breast cancerPatrick Lebok, Hannah Bönte, Martina Kluth, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Nature Communications|December 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancerMigle Mikutenaite, Evdoxia Karadoulama, Francesco Favero, et al.
Clinical & Experimental Metastasis|October 25, 2020
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancerHannah Voß, Marcus Wurlitzer, Daniel J Smit, et al.
BMC Cancer|July 28, 2017
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerFrank Jacobsen, Billurvan Taskin, Nathaniel Melling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
Pageof 50